================================================================================
MEDICAL VALIDATION REPORT
================================================================================

Total predictions validated: 50
High confidence: 0
Medium confidence: 9
Low confidence: 41

================================================================================
HIGH CONFIDENCE PREDICTIONS (Strong Evidence)
================================================================================

================================================================================
MEDIUM CONFIDENCE PREDICTIONS (Partial Evidence)
================================================================================

1. Fluprednisolone acetate → hypercalciuria, absorptive
   Validation Score: 0.5067
   Checklist: 3/6 criteria met

2. 3,5-diiodothyropropionic acid → hypercalciuria, absorptive
   Validation Score: 0.5062
   Checklist: 3/6 criteria met

3. Lidoflazine → hypercalciuria, absorptive
   Validation Score: 0.5062
   Checklist: 3/6 criteria met

4. 4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol → hypercalciuria, absorptive
   Validation Score: 0.5058
   Checklist: 3/6 criteria met

5. Omacetaxine mepesuccinate → hypercalciuria, absorptive
   Validation Score: 0.5057
   Checklist: 3/6 criteria met

6. N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide → Carney complex,
   Validation Score: 0.5055
   Checklist: 3/6 criteria met

7. (2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide → mandibuloacral dysplasia
   Validation Score: 0.5055
   Checklist: 3/6 criteria met

8. N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3,4,5- TRIMETHOXYPHENYL)PYRIMIDINE-2,4-DIAMINE → Carney complex,
   Validation Score: 0.5054
   Checklist: 3/6 criteria met

9. N-Hydroxy 1n(4-Methoxyphenyl)Sulfonyl-4-(Z,E-N-Methoxyimino)Pyrrolidine-2r-Carboxamide → Carney complex,
   Validation Score: 0.5052
   Checklist: 3/6 criteria met

================================================================================
LOW CONFIDENCE PREDICTIONS (Weak Evidence)
================================================================================

1. Aplaviroc → mandibuloacral dysplasia
   Validation Score: 0.4760
   Note: Limited supporting evidence found

2. N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE → Pelger-Huet anomaly
   Validation Score: 0.4760
   Note: Limited supporting evidence found

3. Diphenylacetic acid → mandibuloacral dysplasia
   Validation Score: 0.4757
   Note: Limited supporting evidence found

4. Compound 19 → Carney complex,
   Validation Score: 0.4756
   Note: Limited supporting evidence found

5. N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide → mandibuloacral dysplasia
   Validation Score: 0.4756
   Note: Limited supporting evidence found

================================================================================
END OF REPORT
================================================================================
